COVID-19 Vaccine Trial Begins, and Inovio Pharmaceuticals Price Target Jumps to $17

“Coronavirus.” For most of this year, most people have been just focused on the one — the novel coronavirus dubbed SARS-CoV-19 that has infected the world with a global pandemic of COVID-19. But did you know there are more than just one kind of coronavirus? Did you know the word itself is more of an adjective than a noun?It’s true. “Coronavirus” in fact describes a whole family of viruses typified by their spiky structure that resembles (to some eyes) a “crown,” or “corona” — and as luck would have it, Inovio Pharmaceuticals (INO) may be developing a knack for treating …read more

Source:: Yahoo Finance

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.